Cetera Investment Advisers
DXCM icon

Cetera Investment Advisers’s DexCom DXCM Stock Holding History

Cetera Investment Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.54M Sell
126,816
-1,959
-2% -$131K 0.01% 1252
2026
Q1 		$8.09M Buy
128,775
+7,852
+6% +$547K 0.01% 1191
2025
Q4 		$8.03M Buy
120,923
+44,844
+59% +$2.9M 0.01% 1165
2025
Q3 		$5.12M Buy
76,079
+9,294
+14% +$735K 0.01% 1394
2025
Q2 		$5.83M Sell
66,785
-12,094
-15% -$948K 0.01% 1092
2025
Q1 		$5.39M Buy
78,879
+6,697
+9% +$547K 0.01% 1060
2024
Q4 		$5.61M Buy
72,182
+10,385
+17% +$769K 0.01% 975
2024
Q3 		$4.14M Sell
61,797
-34,354
-36% -$2.82M 0.01% 1109
2024
Q2 		$10.9M Sell
96,151
-10,730
-10% -$1.36M 0.03% 641
2024
Q1 		$14.8M Buy
106,881
+46,297
+76% +$5.82M 0.04% 504
2023
Q4 		$7.52M Buy
60,584
+6,310
+12% +$645K 0.06% 307
2023
Q3 		$5.06M Buy
54,274
+7,910
+17% +$892K 0.04% 410
2023
Q2 		$5.96M Sell
46,364
-224
-0.5% -$27.1K 0.05% 351
2023
Q1 		$5.41M Sell
46,588
-49
-0.1% -$5.49K 0.05% 371
2022
Q4 		$5.28M Buy
46,637
+17,300
+59% +$1.9M 0.05% 370
2022
Q3 		$2.36M Sell
29,337
-2,957
-9% -$250K 0.05% 407
2022
Q2 		$2.41M Buy
32,294
+50
+0.2% +$4.56K 0.04% 466
2022
Q1 		$4.12M Buy
32,244
+1,568
+5% +$172K 0.06% 329
2021
Q4 		$4.12M Buy
30,676
+1,792
+6% +$257K 0.06% 334
2021
Q3 		$3.95M Buy
28,884
+592
+2% +$74.7K 0.06% 320
2021
Q2 		$3.02M Buy
28,292
+16,188
+134% +$1.55M 0.05% 398
2021
Q1 		$1.09M Sell
12,104
-9,584
-44% -$900K 0.02% 634
2020
Q4 		$2M Buy
+21,688
New +$1.94M 0.04% 425

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cetera Investment Advisers's DXCM Position: Q2 2026 in Review

Cetera Investment Advisers reduced its DexCom (DXCM) stake by 1.5% in Q2 2026, selling an estimated $131K and leaving 126,816 shares worth $8.54M. The position accounts for 0.01% of the portfolio, ranked #1252.

Cetera Investment Advisers first reported a position in DXCM in Q4 2020 and has held it in 23 quarters since. The position peaked at $14.8M in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cetera Investment Advisers held 126,816 shares of DexCom worth $8.54M as of Q2 2026.
  • Cetera Investment Advisers sold 1,959 DexCom shares in Q2 2026, an estimated $131K.
  • DexCom made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1252 holding.
  • Cetera Investment Advisers first reported a position in DexCom in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's DexCom position peaked at $14.8M in Q1 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.